Translating cutting-edge research into commercial outcomes and societal benefits is core to the AIBN mission.
Successful commercialisation is not the final step in a linear process, but is ongoing and iterative.
At AIBN, active engagement with commercial partners and potential collaborators facilitates mutual awareness and ensures research is aligned with ‘real world’ challenges.
AIBN’s engagement with industry is multifaceted, including collaborative research projects consulting and commercial contracts.
Where there is no established or accessible company for AIBN’s technology, the Institute nurtures the creation of start-up companies.
AIBN’s commercialisation activities are led by a strong team, consisting of Dr Phil Nelson (Manager, Innovation and Commercial Development) and Dr Lorine Wilkinson(Research Partnerships Managers).